Cotargeting of Bcl-2 and Mcl-1 shows promising antileukemic activity against AML cells including those with acquired cytarabine resistance

Liu, FB; Zhao, QS; Su, YW; Lv, J; Gai, YQ; Liu, S; Lin, H; Wang, Y; Wang, G

Wang, Y (通讯作者)，First Hosp Jilin Univ, Dept Pediat Hematol & Oncol, 71 Xinmin St, Changchun, Jilin, Peoples R China.;Wang, G (通讯作者)，Jilin Univ, Sch Life Sci, 2699 Qianjin St, Changchun, Jilin, Peoples R China.

EXPERIMENTAL HEMATOLOGY, 2022; 105 (): 39

Abstract

Acute myeloid leukemia (AML) remains a clinical challenge. Venetoclax is an effective Bcl-2 selective inhibitor approved by the U.S. Food and Drug Adm......

Full Text Link


Links

期刊讨论 | 中国SCI论文 | 期刊主页 | 投稿经验 | 杂志官网 | 投稿链接 | 作者需知 | PMC链接 | Pubmed全文检索